Literature DB >> 10565926

Demonstration of Bartonella grahamii DNA in ocular fluids of a patient with neuroretinitis.

F T Kerkhoff1, A M Bergmans, A van Der Zee, A Rothova.   

Abstract

We describe the clinical and laboratory features of a 55-year-old human immunodeficiency virus-negative female patient who presented with bilateral intraocular inflammatory disease (neuroretinitis type) and behavioral changes caused by a Bartonella grahamii infection. Diagnosis was based on the PCR analysis of DNA extracted from the intraocular fluids. DNA analysis of the PCR product revealed a 100% identity with the 16S rRNA gene sequence of B. grahamii. The patient was successfully treated with doxycycline (200 mg/day) and rifampin (600 mg/day) for 4 weeks. This is the first report that demonstrates the presence of a Bartonella species in the intraocular fluids of a nonimmunocompromised patient and that indicates that B. grahamii is pathogenic for humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565926      PMCID: PMC85873     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens.

Authors:  D A Relman; J S Loutit; T M Schmidt; S Falkow; L S Tompkins
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

2.  Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease.

Authors:  R L Regnery; J G Olson; B A Perkins; W Bibb
Journal:  Lancet       Date:  1992-06-13       Impact factor: 79.321

3.  Detection of Leptospira DNA by polymerase chain reaction in aqueous humor of a patient with unilateral uveitis.

Authors:  F Merien; P Perolat; E Mancel; D Persan; G Baranton
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

4.  Oculoglandular disease of parinaud. A manifestation of cat-scratch disease.

Authors:  H A Carithers
Journal:  Am J Dis Child       Date:  1978-12

5.  Presumed ocular bartonellosis.

Authors:  F T Kerkhoff; J M Ossewaarde; W S de Loos; A Rothova
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

6.  Rochalimaea antibodies in HIV-associated neurologic disease.

Authors:  W A Schwartzman; M Patnaik; N E Barka; J B Peter
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

7.  Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir.

Authors:  J E Koehler; C A Glaser; J W Tappero
Journal:  JAMA       Date:  1994-02-16       Impact factor: 56.272

8.  Ophthalmic manifestations of Rochalimaea species.

Authors:  K C Golnik; M E Marotto; M M Fanous; D Heitter; L P King; J I Halpern; P H Holley
Journal:  Am J Ophthalmol       Date:  1994-08-15       Impact factor: 5.258

9.  Disseminated cat-scratch disease: detection of Rochalimaea henselae in affected tissue.

Authors:  K Waldvogel; R L Regnery; B E Anderson; R Caduff; J Caduff; D Nadal
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

10.  Cytologically proven seronegative Lyme choroiditis and vitritis.

Authors:  H D Schubert; E Greenebaum; H C Neu
Journal:  Retina       Date:  1994       Impact factor: 4.256

View more
  72 in total

1.  Differentiation of pathogenic Bartonella species by infrequent restriction site PCR.

Authors:  S A Handley; R L Regnery
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 2.  Natural history of Bartonella infections (an exception to Koch's postulate).

Authors:  V Jacomo; P J Kelly; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

3.  The arthropod, but not the vertebrate host or its environment, dictates bacterial community composition of fleas and ticks.

Authors:  Hadas Hawlena; Evelyn Rynkiewicz; Evelyn Toh; Andrew Alfred; Lance A Durden; Michael W Hastriter; David E Nelson; Ruichen Rong; Daniel Munro; Qunfeng Dong; Clay Fuqua; Keith Clay
Journal:  ISME J       Date:  2012-06-28       Impact factor: 10.302

4.  The Bacteriome of Bat Flies (Nycteribiidae) from the Malagasy Region: a Community Shaped by Host Ecology, Bacterial Transmission Mode, and Host-Vector Specificity.

Authors:  David A Wilkinson; Olivier Duron; Colette Cordonin; Yann Gomard; Beza Ramasindrazana; Patrick Mavingui; Steven M Goodman; Pablo Tortosa
Journal:  Appl Environ Microbiol       Date:  2016-01-08       Impact factor: 4.792

5.  Effects of cow age and pregnancy on Bartonella infection in a herd of dairy cattle.

Authors:  R Maillard; B Grimard; S Chastant-Maillard; B Chomel; T Delcroix; C Gandoin; C Bouillin; L Halos; M Vayssier-Taussat; H-J Boulouis
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

6.  Potential limitations of the 16S-23S rRNA intergenic region for molecular detection of Bartonella species.

Authors:  Ricardo G Maggi; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Genome dynamics of Bartonella grahamii in micro-populations of woodland rodents.

Authors:  Eva C Berglund; Christian Ehrenborg; Olga Vinnere Pettersson; Fredrik Granberg; Kristina Näslund; Martin Holmberg; Siv G E Andersson
Journal:  BMC Genomics       Date:  2010-03-04       Impact factor: 3.969

8.  Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis.

Authors:  Boaz Avidor; Merav Graidy; Gabi Efrat; Cecilia Leibowitz; Gregory Shapira; Ami Schattner; Oren Zimhony; Michael Giladi
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

9.  Exotic small mammals as potential reservoirs of zoonotic Bartonella spp.

Authors:  Kai Inoue; Soichi Maruyama; Hidenori Kabeya; Keiko Hagiya; Yasuhito Izumi; Yumi Une; Yasuhiro Yoshikawa
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

10.  Bartonella australis sp. nov. from kangaroos, Australia.

Authors:  Pierre-Edouard Fournier; Carmel Taylor; Jean-Marc Rolain; Lina Barrassi; Greg Smith; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.